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Abstract 15 
Evaluating the gastrointestinal (GI) fate of proteins is part of the assessment to determine whether 16 
proteins are safe to consume. In vitro digestion tests are often used for screening purposes in the 17 
evaluation of potential allergenicity. However, the current pepsin resistant test used by the 18 
European Food Safety Authority, only corresponds to fasted gastric conditions representative of a 19 
late phase adult stomach. In addition, these tests are performed on isolated proteins and the effect 20 
of the food matrix and processing are not systematically considered. The aim of this research is to 21 
compare three different static in vitro GI scenarios that are physiologically relevant. Namely, an 22 
infant, early phase (fed state) adult and late phase (fasted state) adult model. These protocols are 23 
applied to well-characterised isolated dairy (β-lactoglobulin and β-casein) and egg (lysozyme and 24 
ovalbumin) proteins and the impact of food matrix/processing on their proteolysis is also 25 
investigated. A combination of SDS-PAGE, LC-MS/MS and spectrometric assay was used for the 26 
evaluation of the proteolysis. Results highlight differences across the three GI scenarios whether on 27 
isolated proteins or within food matrices. The infant model led to incomplete digestion, leaving 28 
intact egg proteins, either isolated or in the food matrix, and intact β-lactoglobulin in the milk. In 29 
addition, peptides greater than 9 amino acids were found throughout the intestinal phase for all 30 
proteins studied, regardless of the scenario. This reinforces the difficulty of linking protein 31 
digestibility to potential allergenicity because many other factors are involved that need further 32 
investigation. 33 
 34 




1. Introduction 39 
Evaluating the gastrointestinal (GI) fate of proteins is paramount to assess whether they are safe to 40 
consume, including their potential to elicit an allergic reaction. The resistance of proteins to 41 
digestion may be significant in relation to determining their allergenic potential since incomplete 42 
digestion may cause undesired immune responses via sensitisation and/or elicitation in the 43 
duodenum.
1
 Thus, evaluating the digestibility of proteins as part of a suite of assessments and in 44 
vitro protocols seems appropriate when ethical constraints hinder in vivo studies. The in vitro 45 
digestion model most commonly used for this purpose in line with the European Food Safety 46 
Authority (EFSA) guidelines
2, 3
 and Implementing Regulation (EU) No 503/2013 (IR503/2013) is the 47 
pepsin resistance test.
4, 5
 This mimics the gastric phase of digestion with parameters that are not 48 
representative of the normal physiological environment that food is exposed to immediately after 49 
consumption. Namely, it uses gastric conditions that are highly acidic and enzyme concentration that 50 
would simulate the end of gastric emptying (late phase) or fasted state in human adults. A more 51 
realistic approach including a subsequent small intestinal phase and other relevant conditions in 52 
healthy adults or in infants may provide useful information on how the combined effect of pH and 53 
enzyme concentration affects protein digestibility. Therefore, in accordance with the guidance 54 
offered by the EFSA Genetically Modified Organisms (GMO) panel
3
 this study considers a range of 55 
more physiologically relevant conditions that mimic the early phase (or fed state) and late phase (or 56 
fasted state) adult and infant GI environments.  57 
The aim of this research is to compare the three in vitro digestion models in the context of 58 
assessment of the digestibility of proteins. For this purpose, the comparison uses relevant test 59 
proteins that are widely consumed and have previously been characterised to some extent under 60 
simulated GI conditions. In addition, the effect of the food matrix, in which these proteins are 61 
naturally present, on their digestibility will be also evaluated with the three models. Thus, the first 62 
part of this study comprises the in vitro digestion of isolated proteins from bovine milk (β-63 
lactoglobulin, BLG, and β-casein, BCS) and hen’s egg (lysozyme, LYS, and ovalbumin, OVA). These 64 
proteins are all major allergens varying in stability within the GI tract. BLG and BCS represent two 65 
major proteins in bovine milk (allergens Bos d 5 and Bos d 8, respectively) with contrasting 66 
susceptibility to GI digestion, stable versus labile.
6
 LYS and OVA (allergens Gal d 4 and Gal d 2, 67 




 LYS is an enzyme whereas OVA, the most abundant protein in egg white, is a storage protein.  69 
The second part of this study focuses on the in vitro digestion of fresh whole bovine milk and soft-70 
boiled hen’s egg. Both the food matrix and thermal processing effects are taken into account. 71 
Pasteurisation is a standard procedure to ensure microbial stability in milk, and eggs are cooked for 72 
safe consumption and improved sensory properties. Thermal processing may affect the structure of 73 
the natural food matrix, since proteins are partially denatured and conformations are modified, 74 
affecting the stability to digestion.
9
 In addition, thermal processing may enhance protein interactions 75 
with other components in the food matrix, such as lipids and sugars and can affect the digestion of 76 
proteins.
10
 In the current study, the commercial fresh whole milk used was previously pasteurised 77 
(72 °C for a minimum of 15 s) and homogenised. Homogenisation in milk prior to pasteurisation is 78 
also known to affect the ultrastructure by breaking up milk fat globules and changing the interfacial 79 
composition from milk fat globule membrane (MFGM) proteins to whey proteins and casein micelles 80 
and/or their fragments.
11
 The hen’s eggs were soft boiled (boiled individually for 3 min 81 
approximately), as it is very popular in the British breakfast.  82 
The in vitro digestion of milk and egg has been investigated in the literature, although some gaps can 83 
be identified. The digestibility of milk protein has been determined as a function of heating and 84 
homogenisation processes used commercially by the dairy industry,
12
 and even using more 85 
sophisticated in vitro semi-dynamic/dynamic gastric models.
13, 14
 Nevertheless, no combined 86 
comparison has been made between the digestibility of proteins in milk and the digestibility of 87 
isolated proteins, including other human GI conditions. Menard et al. compared the proteolysis 88 
kinetics of an infant formula with the infant and early phase adult models mentioned above.
15
 89 
However, no direct comparison with the digestion of isolated proteins was performed. Similarly, 90 
Egger et al. recently compared the in vitro static (INFOGEST standardised protocol, i.e. early phase 91 
adult) and dynamic digestion of skimmed milk powder proteins with in vivo data.
16
 Their results 92 
showed a good agreement between the gastric and intestinal end points of both in vitro models and 93 
in vivo data from pigs. Martos et al. assessed the effect of the whole food matrix on egg protein 94 
stability to digestion and compared the results with their previous findings on isolated egg 95 
proteins.
17
 Nonetheless, they only considered a single adult model of in vitro digestion and the egg 96 
was not thermally processed (cooked). The effect of heat treatment on the digestion of egg proteins 97 
has been studied on isolated proteins (65 °C for 30 min and 90 °C for 15 min; 80 °C for 6 h),
18-20
 egg 98 
white (56 and 65 °C for 30 min and 100 °C for 5 min; 60 and 80 °C for 10 min)
21, 22
 and in liquid whole 99 
egg (pasteurisation at 60-66 °C for 4-10 min)
23
 but again only a model of adult digestion was used.  100 
The relationship between allergenicity and stability to digestion of a protein is still controversial due 101 
to a lack of knowledge on the exact route of exposure and mechanisms behind food sensitisation 102 
and food allergy.
1, 24
 For this reason, it is of paramount importance to further investigate the 103 
behaviour of known allergens during digestion and identify the products of digestion extensively. In 104 
the present study, SDS-PAGE was used to identify intact protein or protein fragments larger than 5 105 
kDa in digesta samples of isolated proteins and meals. Densitometry analysis of SDS-PAGE allowed 106 
the semi-quantification of hydrolysis of intact protein throughout in vitro GI digestion. LC-MS/MS 107 
was used to identify protein fragments smaller than 5 kDa in digesta samples of isolated proteins. 108 
Only peptides greater than 9 amino acids in length were analysed because of their potential to 109 
induce an immune response due to their likelihood of carrying at least two B-cell receptor 110 
epitopes.
25, 26
 Hydrolysis of total protein in meals was also quantified by measuring the levels of free 111 
amine groups with a spectrophotometric assay.  112 
To the best of our knowledge, this is the first time that the in vitro digestion of these meals has been 113 
compared under physiologically relevant conditions in infants and adults in two different states: fed 114 
versus fasted, and the impact of food matrix/processing assessed by comparison with the 115 
digestibility of isolated proteins. The current study highlights differences in protein digestibility 116 
across the three GI scenarios whether on isolated proteins or within food matrices. In addition, 117 
peptides greater than 9 amino acids were present throughout the intestinal phase for all proteins, 118 
regardless of the model. This emphasises the difficulty of linking digestibility to potential 119 
allergenicity because many other factors are involved that need further investigation.  120 
 121 
2. Materials and methods 122 
All chemicals used were of analytical grade and purchased from Sigma-Aldrich unless otherwise 123 
stated. 124 
2.1 Isolated proteins and meals: source and preparation 125 
Bovine milk proteins β-lactoglobulin (BLG) and β-casein (BCS) were purchased from Merck (Cat. No. 126 
L3908 and C6905, respectively) and used as received. The purity reported by the supplier for those 127 
particular batches was ≥98% for both proteins. Ovalbumin (OVA) from hen’s egg white was purified 128 
and supplied by INRAE Institut Agro according to previously published protocols
27
 whereas lysozyme 129 
(LYS) was kindly provided by Liot (Liot, Pleumartin, France). The purity of the isolated LYS fraction 130 
was 100% and for OVA fraction was ≥85%, as determined by SDS-PAGE, with ovotransferrin being 131 
the main contaminant. All of the isolated proteins were prepared by dispersing the lyophilised 132 
powder in ultrapure water (Milli-Q) and left under mild stirring for at least 1 h at room temperature. 133 
The protein concentration was set at 5 mg/mL in order to be consistent with the concentration used 134 
for BLG based on that in bovine milk, and on the initial test protein concentration used in the original 135 
protocol of the pepsin resistance test.
5
  136 
British fresh whole milk from cow (pasteurised homogenised standardised whole milk) and British 137 
large free-range eggs (Class A) were purchased in a local supermarket and stored in the fridge until 138 
use before the expiry date. Milk was brought to room temperature before in vitro digestion. Each 139 
egg was soft boiled by immersing in boiling tap water (700 mL approximately) for 2 min and 45 140 
seconds. The soft-boiled egg was cooled in tap water for 1 min and once the shell was removed, the 141 
content was mixed well before subjecting to in vitro digestion.   142 
2.2 In vitro digestion protocols 143 
An oral phase preceding the gastric phase has not been considered for consistency with the original 144 
infant protocol,
15
 and because solutions of isolated proteins and both meals are in liquid/semi-liquid 145 
state. In addition, there is no starch present in either meal, therefore the omission of salivary 146 
amylase in an oral phase is justified. 147 
All of the models of in vitro digestion comprised a gastric and subsequent intestinal phase. In the 148 
gastric phase, the enzyme pepsin (4177 U/mg protein) from porcine gastric mucosa (Cat. No. P7012) 149 
was used. In the intestinal phase, individual enzymes trypsin (233 U/mg protein) from porcine 150 
pancreas (Cat. No. T0303) and bovine chymotrypsin (55 U/mg protein) (Cat. No. C4129) were used 151 
for the intestinal digestion of isolated proteins. The extract pancreatin (6.48 Trypsin U/mg solid) 152 
from porcine pancreas (Cat. No. P7545, 8 x USP) was used for the simulated intestinal phase of the 153 
meals and infant and early phase models of BLG and BCAS, and the amount added was based on the 154 
required trypsin activity in the final mixture. Their activities were determined as described in the 155 
electronic supplementary material of Minekus and co-workers.
28
 Bile salts (≥97%) sodium 156 
glycocholate (NaGC) and sodium glycochenodeoxycholate (NaGCDC) with Cat. No. G7132 and 157 
G0759, respectively, were used in the intestinal phase of isolated proteins. Porcine bile extract (Cat. 158 
No. B8631) was used in the intestinal phase of the meals.  159 
In vitro digestion experiments were simulated in 50 mL conical centrifuge tubes mounted 160 
horizontally in a shaking incubator at 37 °C and 100 rpm for better mixing, and were conducted in 161 
triplicate for each model and each protein solution or meal. Control experiments for each model of 162 
in vitro digestion were also carried out by replacing the initial volume/weight of protein 163 
solution/meal by ultrapure water. Sampling was carried out by collecting aliquots of 200 µL at 0.5, 2, 164 
5, 10, 20, 30 and 60 min of both gastric and intestinal phase. Proteases were immediately 165 
inactivated by adding 5 µL of Pepstatin A (0.73 mM) to gastric samples, or 10 µL of Pefabloc® (0.1 M) 166 
to intestinal samples. All samples were frozen at -20 °C until further analysis. 167 
2.2.1 Infant model 168 
The infant static in vitro digestion protocol originally comprises a gastric and intestinal phase in 169 
sequence.
15
 The only adaptation made in the current study was the replacement of bovine bile 170 
extract by either porcine bile extract in the digestion of meals, or an equimolar mixture of NaGC and 171 
NaGCDC, which represent the two major forms in human bile,
29
 in the digestion of isolated proteins.  172 
Briefly, in the gastric phase, 5 mL of isolated protein (5 mg/mL) or 5 g of meal were mixed with infant 173 
simulated gastric fluid (SGF) at a ratio protein solution or meal to SGF of 63:37 (v/v). The pH was set 174 
to 5.3. The infant SGF comprised NaCl (94 mM) and KCl (13 mM), adjusted to pH 5.3 with 1 M HCl. 175 
Pepsin activity was 268 U/mL in the final volume of the gastric chyme. After 60 min of gastric 176 
digestion, the pH was raised to 7 with 1 M NaOH in order to inactivate pepsin before intestinal 177 
digestion. 178 
In the intestinal phase, the gastric chyme was mixed with infant simulated intestinal fluid (SIF) at a 179 
ratio of gastric chyme to SIF of 62:38 (v/v) and adjusted to pH 6.6 with 1 M HCl. The infant SIF 180 
comprised NaCl (164 mM), KCl (10 mM) and NaHCO3 (85 mM) adjusted to pH 7. CaCl2 was added 181 
separately before starting the intestinal phase at a concentration of 3 mM within the volume of the 182 
SIF. The total concentration of bile salts was 3.1 mM in the final volume of the intestinal content. 183 
The trypsin activity was 16 U/mL (also in pancreatin) in the final volume and the chymotrypsin 184 
activity was 4 U/mL. This phase lasted for 60 min. 185 
2.2.2 Early phase adult model 186 
The early phase adult static in vitro digestion protocol follows the INFOGEST international 187 
consensus
28
 with several adaptations. Namely, the oral phase was omitted, the length of gastric and 188 
intestinal phases was 60 min each and an equimolar mixture of NaGC and NaGCDC replaced the bile 189 
extract for the in vitro digestion of isolated proteins, in order to retain consistency with the infant 190 
model. More details of the INFOGEST protocol can be found elsewhere.
30
  191 
Briefly, in the gastric phase, 5 mL of isolated protein (5 mg/mL) or 5 g of meal were mixed with early 192 
phase adult SGF at a ratio protein solution or meal to SGF of 50:50 (v/v) and the pH was set to 3. The 193 
early phase adult SGF comprised NaCl (47.2 mM), KCl (6.9 mM), KH2PO4 (0.9 mM), NaHCO3 (25 mM), 194 
MgCl2(H2O)6 (0.1 mM), and (NH4)2CO3 (0.5 mM) adjusted to pH 3 with 1 M HCl. CaCl2 was added 195 
separately before starting the gastric phase at a concentration of 0.075 mM in the final volume of 196 
the gastric chyme. Pepsin activity was 2000 U/mL in the final volume. After 60 min of gastric 197 
digestion, the gastric chyme was immediately subjected to the intestinal phase. 198 
In the intestinal phase, the gastric chyme was mixed with early phase adult SIF at a ratio gastric 199 
chyme to SIF of 50:50 (v/v) and adjusted to pH 7 with 1 M NaOH. The early phase adult SIF 200 
comprised NaCl (38.4 mM), KCl (6.8 mM), KH2PO4 (0.8 mM), NaHCO3 (85 mM), and MgCl2(H2O)6 (0.33 201 
mM), adjusted to pH 7. CaCl2 was added separately before starting the intestinal phase at a 202 
concentration of 0.3 mM in the final volume. The total concentration of bile salts was 10 mM in the 203 
final volume. The trypsin activity was 100 U/mL (also in pancreatin) in the final volume and the 204 
chymotrypsin activity was 25 U/mL. This phase lasted for 60 min. 205 
2.2.3 Late phase adult model 206 
The late phase adult static in vitro digestion protocol comprised a gastric phase as in the pepsin 207 
resistance test protocol
5
 followed by the intestinal phase of the adult model above. Briefly, in the 208 
gastric phase, 0.5 mL of isolated protein (5 mg/mL) or 0.5 g of meal were mixed with late phase adult 209 
SGF at a ratio protein solution or meal to SGF of 5:95 (v/v). The pH was set to 1.2. The late phase 210 
adult SGF comprised NaCl (35 mM), adjusted to pH 1.2 with 1 M HCl. Pepsin activity was set to 10 211 
U/μg of test isolated protein, which is equivalent to 2500 U/mL in the final volume for the gastric 212 
phase of meals. After 60 min of gastric digestion, the gastric chyme was immediately subjected to 213 
the intestinal phase as in previous section. 214 
2.3 SDS-PAGE analysis 215 
Hydrolysis of protein from isolated source or within the meal matrix with the three protocols of in 216 
vitro digestion was analysed by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-217 
PAGE). This technique allows the identification and semi-quantification of intact protein and protein 218 
fragments larger than 5 kDa. Precast Bolt 4-12% Bis-Tris Plus 1 mm x 10 well gels from Invitrogen 219 
were used according to manufacturer’s instructions. Digesta samples were diluted with ultrapure 220 
water in reducing conditions with dithiothreitol (0.5 M) and with LDS sample buffer 4 x (Invitrogen), 221 
followed by heating to 70 °C for 15 min. Wells were loaded with 1.5 µg of isolated protein or 10.5 µg 222 
of total protein in milk and eggs, taking into account the protein to simulated GI fluid ratio in order 223 
to evaluate the sole impact of the proteolysis. Mark 12 Unstained Standard (Invitrogen) was used as 224 
molecular weight marker. Electrophoresis was carried out in MES SDS running buffer (Invitrogen) at 225 
200 V for 22 min at room temperature. Gels were fixed in methanol/water/acetic acid (40/50/10 226 
v/v) for 1 h, then rinsed for 5 min three times with ultrapure water and stained with SimplyBlue™ 227 
SafeStain (Invitrogen) for 1 h. Distaining was carried out overnight with ultrapure water. Gels were 228 
scanned with Bio-Rad ChemiDoc Imager. Densitometry on bands was performed with the software 229 
Image Lab™ 5.1 (Bio-Rad). The SDS-PAGE was conducted at least in duplicate for isolated proteins 230 
and meals digested in vitro with the three models. Densitometry data are presented as mean values 231 
± standard deviation. Comparison between in vitro digestion models over time was done with two-232 
way ANOVA and post hoc Bonferroni multiple comparison test with a threshold for significance p ≤ 233 
0.05. 234 
2.4 LC-MS/MS analysis 235 
Hydrolysis of isolated proteins with the three in vitro digestion models was analysed by liquid 236 
chromatography with tandem mass spectrometry (LC-MS/MS). This technique allows the 237 
identification of smaller peptides (< 5 kDa). Prior to mass spectrometry analysis, additional Pepstatin 238 
was added to all gastric samples. The gastric samples were diluted to the required protein 239 
concentration for injection into the spectrometer (37 ng of BLG or BCS and 50 ng of LYS or OVA). All 240 
gastric samples were filtered using a 0.45 μm filter before injection of 10 μL. For the intestinal 241 
samples, 10 μL were injected, corresponding to 120 ng of protein (unfiltered) for the infant and early 242 
phase adult models and 6 ng of protein (filtered) for the late phase adult model. The smaller amount 243 
injected for the latter is a limitation from the highly diluted samples of the late phase adult protocol.   244 
For mass spectrometry analysis, a nano-RSLC Dionex U3000 system fitted to a Q-Exactive mass 245 
spectrometer (Thermo Scientific, San Jose, USA) equipped with a nanoelectrospray ion source was 246 
used. Samples were concentrated on a μ-precolumn pepMap100 (C18 column, 300 μm i.d. × 5 mm 247 
length, 5 μm particle size, 100 Å pore size; Dionex, Amsterdam, The Netherlands) and separated on a 248 
PepMap RSLC column (C18 column, 75 μm i.d. x 150 mm length, 3 μm particle size, 100 Å pore size; 249 
Dionex) with a column temperature of 35 °C. Peptide separation was performed at a flow rate of 0.3 250 
μL/min using solvents A [2% (v/v) acetonitrile, 0.08% (v/v) formic acid and 0.01% (v/v) trifluoroacetic 251 
acid (TFA) in HPLC grade water] and B [95% (v/v) acetonitrile, 0.08% (v/v) formic acid and 0.01% (v/v) 252 
TFA in HPLC grade water]. The elution gradient first rose from 5 to 35% solvent B over 40 min, then 253 
up to 85% solvent B over 5 min before column re-equilibration. The mass spectra were recorded in 254 
positive mode using the m/z range 350-3000. The resolution of the mass analyser for m/z of 200 255 
atomic mass units was set in the acquisition method to 70,000 for MS and 17,500 for MS/MS. For 256 
each MS scan, the ten most intense ions were selected for MS/MS fragmentation and excluded from 257 
fragmentation for 20 s. 258 
Peptides were identified from the MS/MS spectra using the X!TandemPipeline software 259 
(http://pappso.inra.fr) against an in-house database composed of the sequence of the proteins to 260 
which was added the common Repository of Adventitious Protein (http://thegpm.org/crap). No 261 
specific enzymatic cleavage was specified and the possible post-translational modifications searched 262 
were serine phosphorylation, methionine oxidation, and deamidation of glutamine or aspartic acid. 263 
Peptides identified with an e-value < 0.01 were automatically validated, giving an evaluated false 264 
discovery rate of less than 1% at the peptide level. Only peptides of minimum 6 amino acids long can 265 
be identified with this strategy.  266 
Data analyses were performed using the R software, version 3.3.1 (R Core Team, 2014). A statistical 267 
analysis of the identified peptides longer than 9 amino acids was performed. Peptides of molecular 268 
weight (Mw) higher than 4 kDa were not detected automatically by the technique.  269 
2.5 OPA assay 270 
The standard ortho-phthaldialdehyde (OPA) spectrophotometric assay
31
 was performed to quantify 271 
the amount of free NH2 groups released during the proteolysis of both meals with the three in vitro 272 
models. This is indicative of the hydrolysis of total protein. Prior to the assay, 5% trichloroacetic acid 273 
(166 µL) was added to digested sample (100 µL) to cause the precipitation of insoluble protein that 274 
could interfere in the analysis, followed by centrifugation at 10,000 g for 30 min at room 275 
temperature. OPA reagent was prepared by dissolving 3.81 g of sodium tetraborate in approximately 276 
80 mL Milli-Q water under stirring at 50 °C. Then, 0.088 g dithiothreitol and 0.1 g sodium dodecyl 277 
sulphate were added after cooling down to room temperature. Finally, 0.080 g OPA dissolved in 2 278 
mL of ethanol was added in the solution that was made up to 100 mL with Milli-Q water. L-leucine 279 
was used as standard. The calibration curve was obtained with different concentrations (0-10 mM) 280 
of the standard solution made in 10 mM phosphate buffer solution. In micro-titre plates, 10 µl of 281 
standard/sample were loaded into each well and mixed with 200 µl of OPA reagent, allowing the 282 
reaction to proceed for 15 min at room temperature. The absorbance was measured at 340 nm 283 
using a microplate photometer (Multiskan FC, ThermoFisher Scientific). Each measurement was 284 
conducted in triplicate. Data are presented as mean values ± standard deviation. Comparison 285 
between in vitro digestion models over time was done with two-way ANOVA and post hoc 286 
Bonferroni multiple comparison test with a threshold for significance p ≤ 0.05. 287 
 288 
3. Results and discussion 289 
Three in vitro digestion protocols have been applied to isolated proteins from bovine milk and hen’s 290 
egg as well as the respective meal. The infant model follows the protocol recently published by 291 
Menard and co-workers,
15
 which is based on in vivo data available in literature, and represents the 292 
mildest digestive conditions tested. In particular, the infant gastric average pH (5.3) is higher than 293 
that in adults (3 in the early phase and 1.2 in the late phase) and is out of the optimum range for 294 
pepsin activity (pH = 1.6-4). Furthermore, the average enzyme activity in the gastric and intestinal 295 
compartment is also lower in the infant model, as is the total concentration of bile acids in the small 296 
intestine. The early phase adult simulation is based on the INFOGEST harmonised protocol from 297 
Minekus and co-workers
28
 that has been validated against in vivo data and its reproducibility has 298 
been confirmed by ring trial.
32
 The late phase adult gastric model follows the current pepsin 299 
resistance test,
5
 which uses a low pH and high pepsin activity compared to the early phase adult 300 
model. This is followed by the intestinal phase of the INFOGEST harmonised protocol. 301 
3.1 In vitro digestion of isolated bovine milk proteins 302 
The digestion of isolated milk proteins, BLG and BCS, was first evaluated with SDS-PAGE and the 303 
results for the three in vitro models are shown in Figure 1A and 1B. The lanes “BLG” and “BCS” 304 
correspond to the protein before digestion and the time points of the gastric and intestinal phase 305 
are given in minutes. The control lanes “C” in both gastric and intestinal phase correspond to the 306 
experiment where the isolated protein was replaced by ultrapure water, thus only show bands of 307 
the digestive enzymes as labelled in the figure. Top pictures (Figure 1 A1, A2, B1, B2) correspond to 308 
the infant model, middle pictures (Figure 1 A3, A4, B3, B4) to the early phase adult model and 309 
bottom pictures (Figure 1 A5, A6, B5, B6) to the late phase adult model.  310 
There are clear differences in the gastric proteolysis of BLG and BCS across the three in vitro models. 311 
Namely, the whey protein BLG is pepsin-resistant throughout the gastric phase (Figure 1 A1, A3, A5), 312 
whereas BCS is rapidly hydrolysed (Figure 1 B1, B3, B5). The band corresponding to intact BLG (18.4 313 
kDa) is present after 60 min of gastric digestion regardless of the model and no bands of smaller Mw 314 
corresponding to hydrolysis products can be visualised. This agrees with the results of pepsin 315 
resistance test for BLG (or gastric late phase adult model) reported by Thomas and co-workers.
5
 316 
Conversely, the band corresponding to intact BCS (23.8 kDa) disappears at different rates depending 317 
on the model and is no longer visible after 60 min of infant gastric digestion. This is more accurately 318 
shown in the percentage of intact protein determined from densitometry analysis on bands (Figure 319 
1C and 1E). The contrasting susceptibility of BLG and BCS to pepsin digestion is well-known and is 320 
related with the nature of both proteins, globular versus open structured, respectively. In particular, 321 
most of the pepsin cleavage sites are buried in the hydrophobic core of BLG.
33
  322 
As BCS is susceptible to pepsin, different gastric digestion is expected for this protein across the 323 
three models. It is worth noting that in the late phase adult model, the pepsin to test protein ratio is 324 
the greatest of the three protocols of in vitro digestion (10000 U/mg of test protein), followed by the 325 
early phase adult model (800 U/mg of test protein) and the infant model (85 U/mg of test protein). 326 
For this reason, the intensity of the band corresponding to pepsin (34.6 kDa) is greater in the late 327 
phase adult model than in the early phase adult model and essentially invisible in the infant model. 328 
Therefore, the limited proteolysis of BCS was observed for the infant protocol, followed by 329 
intermediate and extensive hydrolysis for the early and late phase adult models, respectively. In the 330 
infant model (Figure 1 B1), BCS was partially hydrolysed by pepsin after 30 s and bands of lower Mw, 331 
4-22 kDa peptides, corresponding to hydrolysis products, are already visible and become more 332 
intense at 10 min. Their intensity gradually decreases afterwards, although these peptides are still 333 
visible at 60 min of the gastric phase. In the early phase adult model (Figure 1 B3), only bands 334 
corresponding to protein fragments smaller than 20 kDa are visible after 30 s of gastric digestion and 335 
peptides smaller than 5 kDa are detected afterwards, which gradually decrease in intensity until the 336 
end of the gastric phase. Figure 1E also shows a faster disappearance (at 30 s) of intact BCS during 337 
the gastric phase for the early phase adult model, as compared to the infant one. As discussed by 338 
Menard and co-workers,
15
 the slower kinetics of BCS gastric digestion in the infant model is largely 339 
due to the loss of pepsin activity at pH 5.3, ~ 10% of its activity at pH 2,
34
 as compared to the optimal 340 
pepsin activity at pH 3 in the early phase adult model, rather than the content of pepsin. Indeed, a 341 
previous study reported similar BCS gastric digestibility for an infant and adult model working with 342 
similar differences in pepsin content (8-fold lower in the infant) but closer pH values (2.5 and 3 for 343 
adult and infant, respectively).
6
 The gastric proteolysis of BCS is even faster for the late phase adult 344 
model and only a faint band corresponding to protein fragments of 5 kDa approximately is observed 345 
after 30 s of gastric digestion, and this is not visually detectable after 5 min (Figure 1 B5). This 346 
greater extent of BCS hydrolysis in terms of peptides is not visible in the percentage of intact BCS in 347 
the gastric phase of both adult models (Figure 1E). 348 
 349 
 350 
Figure 1: SDS-PAGE of the digesta of isolated BLG (A) and BCS (B) with the infant, early phase adult 351 
and late phase adult models. The numbers at the top of the lanes represent the time in min of the 352 
gastric or intestinal phase. The M lane corresponds to the Mw marker. BLG and BCS lanes are the 353 
protein blank and the C lane is the control of the digestive enzymes. Percentage of intact protein C), 354 
D) BLG and E), F) BCS within the gastric or intestinal phase determined from densitometry on SDS-355 
PAGE (n ≥ 2). Different letters mean significant differences (p ≤ 0.05) between models over time. 356 
Absence of letters means no significant differences. 357 
 358 
A different story is observed in the intestinal phase, where BLG was significantly hydrolysed even 359 
under the milder conditions of the infant model (Figure 1 A2). This agrees with the rapid intestinal 360 
digestion of BLG present in infant formula.
15
 A very faint band of ~ 3 kDa appears after 30 s of 361 
intestinal digestion, which gradually vanishes afterwards suggesting almost complete hydrolysis by 362 
intestinal proteases (see also Figure 1D). BCS seems to be fully digested after 30 s of intestinal 363 
digestion (Figure 1 B2 and F) although it was already largely hydrolysed by the end of the gastric 364 
phase. The rest of the bands present in the intestinal phase correspond to the enzymes in the 365 
pancreatin extract. In the early phase adult model (Figure 1 A4, B4), the SDS-PAGE suggests that 366 
both proteins seem to be completely digested after 30 s of intestinal digestion (see also Figure 1D 367 
and 1F). A faster duodenal digestion is expected since the intestinal enzymes to test protein ratio is 368 
also larger in the early phase adult model (68.8 trypsin U/mg test protein) as compared to the infant 369 
model (6.75 trypsin U/mg test protein). This is reflected in the greater intensity of the bands 370 
corresponding to pancreatin enzymes. Dupont and co-workers reported much slower kinetics and 371 
lower extent of hydrolysis of BLG with an infant and adult intestinal digestion as compared to our 372 
results.
6
 This could be partially explained by the use of phospholipids vesicles in their study, which is 373 
known to protect BLG against pancreatic proteases degradation.
35
 More importantly, the 374 
trypsin/chymotrypsin to test protein ratio used in the present protocols are higher. Regarding the 375 
intestinal phase in the late phase adult model, Takagi and co-workers also reported the rapid 376 
digestion of BLG under intestinal conditions that would correspond to the late phase adult model in 377 
the current study, although without previous gastric digestion.
36
 The bands shown in the intestinal 378 
phase of the late phase adult model correspond to trypsin and chymotrypsin (Figure 1 A6, B6). These 379 
individual enzymes replaced the pancreatin extract in the remaining digestion experiments on 380 
isolated proteins because the greater intensity of the bands corresponding to the complex mixture 381 
of enzymes in pancreatin makes difficult the interpretation of the SDS-PAGE results.  382 
The size of the peptides successfully identified by LC-MS/MS in at least two of the three replicates 383 
from BLG and BCS digestion at each time point is presented in Figure 2. The number of peptide 384 
sequences identified in total for each model of digestion is summarised in Table 1. The data in the 385 
box plots indicate the peptides in the gastric phase from BLG (Figure 2a) were much smaller (< 3 386 
kDa) than those observed from BCS (≤ 4 kDa) (Figure 2b). Despite the fact that SDS-PAGE showed 387 
that BLG was largely unaffected by pepsin, regardless of the digestion model (Figure 1A and 1C), the 388 
LC-MS/MS data demonstrate that a relatively large number of different peptides (72 in total from 389 
the three models) were still detected (Table 1) but were most likely in low abundance. Only a small 390 
proportion of BLG was hydrolysed by pepsin during the gastric phase, showing no difference in the 391 
band intensity of the intact protein on SDS-PAGE gels for the infant and early phase adult models. 392 
However, approximately 20% of intact BLG was hydrolysed in the late phase adult model as seen in 393 
Figure 1C and a larger number of gastric peptides (53) was also identified in this model, compared to 394 
those in the early phase (42) and infant model (32) (Table1). For BLG, the median Mw values are 395 
quite similar in the gastric phase between the early and the late phase adult model, with median 396 
values decreasing slightly over time. The infant model led to peptides of higher Mw also decreasing 397 
over time. In the late phase adult model, pepsin was able to release rather larger peptides of 2.8 kDa 398 
whereas the highest Mw observed with the early phase model was around 2.1 kDa. In the intestinal 399 
phase, BLG generated peptides with Mw tending to be higher than in the gastric phase. This can be 400 
explained by a much larger proportion of the protein being hydrolysed (Figure 1A and 1D) leading to 401 
more diversity in the peptides released. With the infant and early phase adult models, peptide Mw 402 
tended to decrease over digestion time whereas the opposite tendency was seen with the late phase 403 
adult model. The low number of peptides identified in the late phase adult intestinal samples (Table 404 
1) could be the result of the smaller amount injected compared to the infant and early phase adult 405 
models. In summary, a total of 72 unique peptides were identified in the gastric phase after in vitro 406 
digestion of BLG with the three models and 138 in the intestinal phase (Table 1). The larger number 407 
of peptides identified in the intestinal phase as compared to the gastric phase positively correlates 408 
with a greater extent of proteolysis. 409 
 410 
 411 
Figure 2: A box plot of peptide molecular weight from BLG (a) and BCS (b) after gastric and intestinal 412 
digestion with the three in vitro models. Numbers at the bottom are the number of unique peptide 413 
sequences identified at each time point. 414 
 415 
In contrast to BLG, a total of 472 peptides were unambiguously identified for BCS in the gastric 416 
phase, whereas only 296 were found in the intestinal phase (Table 1). The fact that BCS generated a 417 
larger number of unique peptides in the gastric phase is certainly related to the greater extent of 418 
hydrolysis by pepsin (Figure 1B and 1E). In the gastric phase, the median values of the peptide Mw 419 
observed with the infant model are higher than those in the early phase adult model, which in turn 420 
are higher than those in the late phase adult model (Figure 2b). This confirms a more intense 421 
proteolysis in the adult models and in particular with the late phase. There is a tendency of the 422 
median Mw value to decrease over time regardless of the in vitro digestion model. In the intestinal 423 
phase, median Mw values were much lower than those for the gastric phase, indicating further 424 
extent of hydrolysis into smaller peptides and in agreement with SDS-PAGE results in terms of 425 
protein fragments of Mw smaller than 5 kDa (Figure 1B). Among the three protocols, the infant 426 
model led to peptides with highest Mw as expected. With the infant and early phase adult model, 427 
median Mw value decreased consistently over time, which was not the case with the late phase 428 
adult model. 429 
In general, the total number of unique peptides identified in the gastric phase increases in the order 430 
infant < early phase ≤ late phase for BLG and BCS and the opposite is observed in the intestinal 431 
phase (Table 1). There may be a positive correlation between the number of unique peptides 432 
identified in every digestion product and their in vitro digestibility in the gastric compartment.   433 
 434 
Table 1: Summary of the total number of unique peptide sequences identified for the gastric and 435 
intestinal phase of each in vitro digestion model and unambiguously with the three models. 436 






BLG Gastric 72 32 42 53 
Intestinal 138 136 63 40 
BCS Gastric 472 224 292 264 
Intestinal 296 170 99 40 
LYS Gastric 16 4 3 16 
Intestinal 20 20 17 7 
OVA Gastric 91 36 88 85 
Intestinal 434 406 286 163 
 437 
 438 
3.2 In vitro digestion of isolated hen’s egg proteins 439 
The proteolysis of isolated egg proteins, LYS and OVA, were first analysed by SDS-PAGE and the 440 
results are shown in Figure 3A and 3B for the three models of in vitro digestion. Figure 3C-F displays 441 
the calculated percentage of intact protein from densitometry on bands. Figure 3A shows the LYS 442 
band with a Mw of around 14.3 kDa that seems unaffected by pepsin throughout the gastric phase 443 
in the infant and early phase adult model (Figure 3 A1, A3), which is also reflected in the 444 
densitometry analysis in Figure 3C. There is only a statistically significant decrease of the intensity of 445 
the band of intact LYS at 20 min of the gastric phase in the late phase adult model (Figure 3C) and a 446 
faint band of much lower Mw, 2-3 kDa, appeared (Figure 3 A5) corresponding to hydrolysis products. 447 
The band of intact LYS had completely disappeared after 60 min of the gastric phase in this model. 448 
The resistance of LYS to pepsin digestion agrees well with the results reported by Fu and co-workers 449 
under conditions of the gastric late phase adult model or pepsin resistance test.
7
 However, intact LYS 450 
could be seen in their SDS-PAGE until 60 min of the gastric phase, which contrasts with our results, 451 
where intact LYS could be seen until 30 min (Figure 3 A5). This difference might be caused by 452 
differences in pepsin activity as Fu et al. added the enzyme by weight rather than activity making it 453 
difficult to compare.  454 
In contrast to LYS, OVA was more susceptible to pepsin digestion, at least under conditions of the 455 
early and late phase adult models (Figure 3 B3, B5). The intensity of the band corresponding to intact 456 
OVA (Mw ~ 45 kDa) remains constant throughout the infant gastric digestion (Figure 3 B1 and E). In 457 
the early phase adult model, the proteolysis starts to be statistically significant after 20 min of the 458 
gastric phase as shown by the decrease of band intensity (Figure 3E) and appearance of protein 459 
fragments of slightly lower Mw and much smaller hydrolysis products of Mw of 3-4 kDa (Figure 3 460 
B3). A larger extent of OVA gastric digestion was found with an infant model by Dupont and co-461 
workers,
6
 which is likely due to the lower gastric pH (pH 3) used in their study that is more optimal 462 
for pepsin activity, 70% of the maximum in comparison to 10% at pH 5.3.
34
 This also demonstrates 463 
the importance of setting a relevant pH because it affects the enzymatic activity. The rate of OVA 464 
gastric proteolysis in an adult model was also slightly faster in their study, but the gastric extent is 465 
very similar to that obtained here (ca. 20%). In the late phase adult model (Figure 3 B5), the 466 
proteolysis occurs at earlier times, 5 min, as seen in Figure 3E, although intact OVA could still be 467 
seen at 30 min. This is in complete agreement with the results of pepsin resistance test obtained in 468 
the majority of laboratories (6 out of 9) in a ring trial.
5
 Furthermore, the densitometry profile shown 469 
in Figure 3E greatly resembles that reported by Takagi and co-workers for the pepsin resistance test 470 
of OVA.
36
  471 
 472 
 473 
Figure 3: SDS-PAGE of the digesta of isolated LYS (A) and OVA (B) with the infant, early phase adult 474 
and late phase adult models. The numbers at the top of the lanes represent the time in min of the 475 
gastric or intestinal phase. The M lane corresponds to the Mw marker. LYS and OVA lanes are the 476 
protein blank and the C lane is the control of the digestive enzymes. Percentage of intact protein C), 477 
D) LYS and E), F) OVA within the gastric or intestinal phase determined from densitometry on SDS-478 
PAGE (n ≥ 2). Different letters mean significant differences (p ≤ 0.05) between models over time. 479 
Absence of letters means no significant differences. 480 
 481 
Different intestinal proteolysis can also be observed across models and between proteins. In 482 
general, the proteolysis was slower and reached a lower extent in the infant model, intermediate 483 
behaviour occurred in the early phase adult model, and faster and greater extent was reached in the 484 
late phase adult model (Figure 3D and 3F). Although both proteins were already hydrolysed by the 485 
end of the gastric phase in the late phase model. OVA seemed to attain the maximum extent of 486 
digestion at the beginning of the intestinal phase, regardless of the model (Figure 3F), also in terms 487 
of appearance of hydrolysis products. This contrasts with LYS kinetics of intestinal proteolysis. In 488 
particular, in the early phase adult model, OVA was largely hydrolysed in the gastric phase whereas 489 
LYS was mostly digested in the intestinal phase (Figure 3D). This suggests that LYS is more 490 
susceptible to pancreatic enzymes while OVA is relatively resistant, which confirms previous findings 491 
on OVA intestinal stability without previous gastric phase.
36
 Both large protein fragments (36-45 492 
kDa) and low molecular weight hydrolysis products (3 kDa) appeared across the intestinal phase of 493 
the early phase adult model (Figure 3 B4). Interestingly, the final extent of digestibility is similar for 494 
both proteins at the end of the intestinal phase within each model (Figure 3D and 3F). Specifically, 495 
approximately 40-50% of intact protein remains in the infant model, 10-20% in the early phase adult 496 
model and 0% in the late phase adult model. The varying extent of protein intestinal digestion across 497 
the three models can be ascribed not only to the different trypsin/chymotrypsin to test protein ratio, 498 
but also to the different concentrations of bile salts. It has been shown that greater bile salt 499 
concentration accelerates the rate of proteolysis for certain dietary proteins.
37
 The kinetics and 500 
extent of OVA intestinal proteolysis in the infant and early phase adult model agree very well with 501 
previous results.
6
 The different extent of proteolysis of LYS and OVA at the end of the intestinal 502 
phase for each in vitro digestion model emphasises the relevance of considering different GI 503 
scenarios representative of the physiological situation in adults and infants. The fact that a protein is 504 
fully hydrolysed in the late phase adult model does not necessarily imply complete digestion with 505 
the other two models. Therefore, the current pepsin resistance test (corresponding to the gastric 506 
late phase adult model) may only be suitable for a first screening, whereby proteins that are 507 
resistant to digestion under these harsh conditions are not expected to be digested under the milder 508 
conditions of the early phase adult or infant models.  509 
LC-MS/MS data indicate that LYS only generated 16 unique peptides during in vitro digestion in the 510 
gastric phase and 20 unique peptides in the intestinal phase in total across the three models (Table 511 
1). These low numbers of peptides are in accordance with the high resistance of LYS to GI digestion 512 
seen by SDS-PAGE with the infant and early phase adult model, and confirm previously published 513 
results.
8
 It was shown in that study that the resistance of LYS to pepsin digestion is due to its rigid 514 
structure given by the four disulphide bridges and proteolysis only occurred at a highly acidic pH 515 
range from 1.2 to 2, likely because of the slightly increased flexibility of LYS at this pH.
38
 It is 516 
therefore reasonable to identify more peptides in the gastric compartment with the late phase adult 517 
model (16) than with the other two models (4 in the infant model and 3 in the early phase adult 518 
model) (Table 1). In addition, it has been shown that when cleaved by pepsin, LYS leads to the 519 
formation of peptides of Mw less than 4-5 kDa,
8
 which are not readily detectable by the LC-MS/MS 520 
protocol used in the current study (Figure 4a). Indeed, SDS-PAGE showed the appearance of 521 
hydrolysis products of around 3.5 kDa at 20 min of the gastric late phase adult model (Figure 3 A5). 522 
In the intestinal phase, LYS has been shown to precipitate in the presence of bile salts making it quite 523 
resistant to proteolysis.
8
 In any case, since the number of peptides coming from LYS clearly identified 524 
is rather low (Table 1), the statistical analysis of the dataset does not bring much relevant 525 
information. 526 
 527 
Figure 4: A box plot of peptide molecular weight from LYS (a) and OVA (b) after gastric and intestinal 528 
digestion with the three in vitro models. Numbers at the bottom are the number of unique peptide 529 
sequences identified at each time point. 530 
 531 
Among the peptides produced from OVA in the gastric phase, those from the early and late phase 532 
adult models were of higher Mw compared to peptides from the infant model (Figure 4b), although 533 
the trend in time of the median Mw shows values slightly higher in the infant model and similar 534 
between the two adult models. This gastric behaviour follows a similar trend to that for BLG and BCS 535 
(Figure 2), confirming a more intense proteolysis in the adult models. The median Mw values of the 536 
peptides decreased on average slightly with time, regardless of the model. Peptides from OVA of 537 
much larger Mw were identified in the intestinal phase, which may be attributable to a larger 538 
proportion of the protein being hydrolysed by intestinal enzymes (Figure 3B). This leads to more 539 
diversity in the peptides released and resembles the behaviour found for BLG in Figure 2a, where 540 
larger peptides were indentified in the intestinal phase compared to the gastric phase. In this case, 541 
peptides of higher Mw were seen in the infant model, followed by the early phase and late phase 542 
adult models, which may be explained by the lower extent of proteolysis in the infant model (Figure 543 
3B and 3F). Only in the infant and late phase adult models was evolution of peptide size, median 544 
Mw, with time observed. In summary, a total of 91 unique peptides were identified in the gastric 545 
phase after in vitro digestion of OVA and 434 in the intestinal phase across the three models (Table 546 
1). The larger number of peptides identified in the intestinal phase as compared to the gastric phase 547 
positively correlates with a greater extent of proteolysis. 548 
As a general trend and as for isolated milk proteins, the number of unique peptides identified in the 549 
gastric phase increases in the order infant ≤ early phase ≤ late phase for LYS and OVA and the 550 
opposite is observed in the intestinal phase (Table 1). Therefore, this confirms a positive correlation 551 
between the number of unique peptides identified in the gastric compartment and the in vitro 552 
digestibility. This is inconclusive in the intestinal stage.  553 
 554 
3.3 Impact of the food matrix/processing on in vitro protein digestion 555 
The in vitro digestion of proteins in bovine milk with the three models was first monitored with SDS-556 
PAGE and results are shown in Figure 5A, with particular focus on BLG and BCS. In this case, the lane 557 
labelled as “Milk” corresponds to the meal blank before digestion, showing the band corresponding 558 
to intact BCS within the group of bands of caseins, and BLG band at lower Mw. The whey protein α-559 
lactalbumin (allergen Bos d 4) of around 14.2 kDa can also be seen below the BLG band, as well as 560 
MFGM proteins at higher molecular weight (> 55 kDa) and bovine serum albumin (allergen Bos d 6) 561 
(66.5 kDa).
14
 The control lane “C” in the intestinal phase corresponds to the digestive enzymes 562 
present in pancreatin. This complex pancreatic mixture represents a more realistic environment and 563 
was used to digest in vitro the food matrix (milk and eggs). Despite the difficulty of reading SDS-564 
PAGE at relatively large concentrations of pancreatin, i.e. in the late phase adult model, some useful 565 
information can still be inferred from the comparison with the infant and early phase adult models. 566 
The gastric digestibility profile of BLG and BCS in the whole milk matrix (Figure 5B and 5D) follows a 567 
similar trend for the three in vitro models as compared to the isolated proteins. The results from 568 
isolated proteins (lines in Figure 5B-E) are also included as a reference. Namely, BLG resisted 569 
hydrolysis throughout the gastric phase regardless of the model, whereas BCS was susceptible to 570 
pepsin digestion and its hydrolysis was instantaneous upon starting the gastric phase in the late 571 
phase adult model, whereas it was slower in the early phase adult and infant models. Although the 572 
impact of the food matrix on protein digestion is expected to be less relevant in milk because it is a 573 
liquid, the effect of thermal processing and homogenisation needs to be considered as well. It has 574 
been reported that the temperature of the pasteurisation process (72 °C) was not sufficient to cause 575 
any important changes in the in vitro gastric digestion of milk proteins as compared to raw milk 576 
(non-heated).
14
 The latter study was carried out with a semi-dynamic gastric model and comparing 577 
milk matrices, not with isolated proteins. Nevertheless, a fast comparison in Figure 5D reveals slight 578 
but significant differences, at least in the dynamics of the early phase adult model. BCS, as part of 579 
the milk matrix, displays a slightly slower rate of gastric proteolysis with the infant and early phase 580 
adult models as compared to the isolated BCS in water, but the final extent is similar. It is known 581 
that heating above 70 °C induces the denaturation of whey proteins, and that denatured whey 582 
proteins bind to κ-casein, both at casein micelle surface and in serum phase.39 This complexation 583 
with the surface of casein micelles may exert a protective effect and slightly delay the hydrolysis of 584 
BCS as compared to isolated non-heated BCS in aqueous solution. Tunick and co-workers showed a 585 
slightly higher resistance of BCS to pepsinolysis in homogenised pasteurised whole milk as compared 586 
to raw milk during the first 15 min of gastric in vitro digestion, as seen by SDS-PAGE.
12
 Sanchez-587 
Rivera et al. reported a noticeable increased resistance of the casein fraction to pepsin digestion in 588 
heated skimmed milk proteins as compare to unheated sample in dynamic in vitro gastric 589 
digestion.
40
 However, it must be taken into account the higher heating temperature used in the 590 
latter study (90 °C), the non-fat nature of the milk, and the dynamic model of the gastric phase. One 591 
could also argue that the enzyme/substrate ratio is lower in the in vitro digestion of meals than for 592 
isolated proteins due to the larger protein content. For instance, the concentration of total protein 593 
in milk is 35 mg/mL approximately as compared to 5 mg/mL in isolated protein samples. 594 
Nevertheless, the enzyme/substrate ratio should still be high enough to overcome any inhibitory 595 
effect.  596 
On the other hand, a rapid BLG hydrolysis was observed in the intestinal phase of milk for both adult 597 
models as for isolated BLG (Figure 5C). However, BLG in the milk matrix exhibits lower extent of 598 
intestinal digestion with the infant model as compared to the isolated BLG in water. The most 599 
plausible explanation is that the average gastric pH in the infant model (5.3) induced milk 600 
coagulation.
41
 It has been reported that BLG is present in the clots of heated homogenised milk 601 
going through a dynamic gastric simulation.
13
 Heating causes the association of whey proteins with 602 
casein micelles and the association of non-micelle-bound whey protein and κ-casein into complexes, 603 
which associate with the micelles at pH values ≤ 5.3.41 This may have protected BLG from pancreatic 604 
enzymes upon gradual intestinal digestion of the clots. Indeed, the static infant gastric model of this 605 
study would be closer to the initial stages of an adult dynamic gastric model, with more elevated pH, 606 
due to the buffering capacity of the meal. It has been shown that the kinetics of digestion of milk 607 
proteins varies according to the in vitro digestion model applied: static versus semi-dynamic.
14
 The 608 
semi-dynamic model was designed to replicate some realistic behaviour found in the stomach in 609 
vivo.
42
 The semi-dynamic model considers not only the buffering capacity of the meal, which 610 
increases the gastric pH immediately after meal intake, but also the gradual acidification with the 611 
progressive secretion of the gastric fluid containing the enzymes, and the gastric emptying. 612 
Therefore, in a more realistic scenario, caseins from milk coagulate in the stomach, which affects 613 
their digestibility and delays their gastric emptying, as compared to BLG that empties throughout the 614 
gastric phase. However, this observation does not apply for UHT-treated milk.
14
 Thus, food 615 
processing is another factor to be taken into account. Regardless of these potential issues, Egger and 616 
co-workers compared the digestion of milk proteins in vivo and in vitro (INFOGEST consensus 617 







Figure 5: SDS-PAGE of the digesta of fresh whole milk (A) with the infant, early phase adult and late 623 
phase adult models. The numbers at the top of the lanes represent the time in min of the gastric or 624 
intestinal phase. The M lane corresponds to the Mw marker. The Milk lane is the meal blank and the 625 
C lane is the control of the digestive enzymes. Percentage of intact protein B), C) BLG and D), E) BCS 626 
within the gastric or intestinal phase of milk (symbols) determined from densitometry on SDS-PAGE 627 
(n ≥ 2). Different letters mean significant differences (p ≤ 0.05) between models over time. Absence 628 
of letters means no significant differences. Lines are results from isolated proteins in Figure 1.  629 
 630 
Figure 6A shows the proteolysis during the in vitro digestion of soft-boiled hen’s egg with the three 631 
models. The lane labelled as “Egg” corresponds to the meal blank before digestion, showing the 632 
bands corresponding to OVA and LYS. Other egg white proteins can also be identified, such as 633 
ovomucins above 95 kDa, ovotransferrin (allergen Gal d 3) of around 76 kDa, and ovomucoid 634 
(allergen Gal d 1) of approximately 28 kDa, but with higher apparent Mw (around 36.5 kDa) due to 635 
its high degree of glycosylation.
17
 Egg yolk proteins can also be detected: α-livetin (allergen Gal d 5) 636 
of around 70 kDa. In general, the GI proteolysis of LYS and OVA as part of the soft-boiled egg matrix 637 
follows a similar trend (Figure 6B-E) to the isolated proteins in aqueous solution. Namely, a lower 638 
extent of hydrolysis is seen for the infant model, intermediate extent for the early phase adult model 639 
and larger extent for the late phase adult model. Nevertheless, there were differences in the in vitro 640 
digestion of both proteins regarding the effect of the food matrix and processing, i.e. soft boiling. 641 
LYS was hydrolysed faster within the egg matrix throughout the gastric and intestinal phase 642 
regardless of the model (Figure 6B and 6C), although the maximum extent of hydrolysis at the 643 
beginning of the intestinal phase was similar to that attained for isolated LYS in aqueous solution at 644 
the end of the intestinal phase. Specifically, 40-50% intact LYS remains in the infant model, 10-20% 645 
in the early phase adult model, and 0% in the late phase adult model. Martos and co-workers 646 
reported a slightly higher susceptibility of raw egg white protein to GI hydrolysis in the presence of 647 
egg yolk, although an increased amount of intact LYS was found after intestinal digestion.
17
 The 648 
authors attributed these results to the presence of components in the egg yolk, such as 649 
phosphatidylcholine, that partially prevents LYS precipitation in the presence of bile salts in the 650 
intestinal phase,
8
 and soluble LYS seemed to be resistant to proteolysis. The faster LYS digestion 651 
observed in our current study may be explained by thermal processing. Wang and co-workers 652 
reported greater egg white protein digestibility when separated from egg yolk in hard-boiled egg as 653 
compared to raw egg stored at 4 °C.
21
 In addition, Liu et al. reported increased digestibility of LYS 654 
and OVA in egg white when heated at 80 °C at a wide range of pH (4-9).
22
 However, OVA attained a 655 
lower extent of digestion within the egg matrix during the gastric phase for both adult models 656 
(Figure 6D), although a similar extent was reached over the course of the intestinal phase regardless 657 
of the model (Figure 6E), compared to isolated OVA in aqueous solution. Heat-induced (80 °C for 6 h) 658 
denaturation and aggregation of isolated OVA has been shown to enhance its in vitro 659 
gastrointestinal digestion due to exposure of additional proteolytic cleavage sites that are hidden in 660 
the native state.
19, 20
 The same was observed when heating OVA at higher temperature (100 °C for 5 661 
min).
36
 However, the lower extent of pepsinolysis of OVA within the egg matrix in the current study 662 
as compared to non-heated isolated OVA might be caused by posttranslational modifications, such 663 
as glycosylation in the presence of reducing sugars like glucose during cooking.
18
 Additionally, it 664 
could be due to a limited access of the enzyme cleavage sites in the semi-solid matrix, and once the 665 
matrix structure has been broken down at the end of the gastric phase, there is no difference 666 
between the intestinal digestion of isolated OVA and within the soft-boiled egg. Martos and co-667 
workers observed a lower extent of duodenal digestion of OVA in the whole raw egg matrix as 668 
compared to isolated OVA and attributed the effect to the presence of ovomucoid, a trypsin 669 
inhibitor that partially retains its inhibitory activity after pepsin digestion.
17
 We have not found 670 
significant differences in the intestinal digestion of intact OVA when in the soft-boiled egg matrix or 671 
isolated. Therefore, soft boiling the egg may have affected the inhibitory activity of ovomucoid.
43
 672 
However, this inhibitory effect may only be relevant in the infant model where ovomucoid (36.5 673 
kDa) seems to resist pepsin digestion. In summary, the effect of the egg matrix and processing, i.e. 674 
soft-boiling, had an impact on the kinetics of protein hydrolysis and gastric end point, but not on the 675 
intestinal end point. 676 
 677 
 678 
Figure 6:  SDS-PAGE of the digesta of soft-boiled egg (A) with the infant, early phase adult and late 679 
phase adult models. The numbers at the top of the lanes represent the time in min of the gastric or 680 
intestinal phase. The M lane corresponds to the Mw marker. The Egg lane is the meal blank and the 681 
C lane is the control of the digestive enzymes. Percentage of intact protein B), C) LYS and D), E) OVA 682 
within the gastric or intestinal phase of egg (symbols) determined from densitometry on SDS-PAGE 683 
(n ≥ 2). Different letters mean significant differences (p ≤ 0.05) between models over time. Absence 684 
of letters means no significant differences. Lines are results from isolated proteins in Figure 3. 685 
 686 
The densitometry analysis on SDS-PAGE to determine the digestibility of specific proteins within the 687 
food matrix might not be completely accurate since some peptides coming from the hydrolysis of 688 
higher Mw proteins can also correspond to the Mw of intact proteins. However, in terms of total 689 
protein, one can still appreciate obvious differences in the digestibility of milk and egg proteins 690 
across the three in vitro models (Figures 5A and 6A). Regarding proteolysis in milk, SDS-PAGE shows 691 
a faster disappearance of bands corresponding to MFGM proteins (> 55 kDa), bovine serum albumin 692 
(66.5 kDa) and α-lactalbumin (14.2 kDa) in the adult models as compared to the infant model (Figure 693 
5A). This can also be generalised for the hydrolysis of other proteins in the egg matrix, such as high 694 
Mw ones (>55 kDa) and proteins bands at around 31 and 36.5 kDa (Figure 6A). 695 
To further assess the effect of the different simulated GI conditions on protein digestibility in the 696 
food matrix, the OPA assay was performed on digesta samples to quantify the hydrolysis of total 697 
protein and results were compared across models. Figure 7 displays the levels of free amine groups 698 
normalised per mg of initial total protein before digestion. These levels are given in units of number 699 
of moles instead of molar concentration to account for the different volumes or dilution factors in 700 
each in vitro digestion model. The values were corrected for the level of free amine groups present 701 
in the control of digestive enzymes. In general, the amount of released free amine groups increases 702 
over time as the protein hydrolysis proceeds in the gastric and the intestinal phase.
14, 22
 Differences 703 
in kinetics and extent of total protein digestion are observed between in vitro models for both meals 704 
following the trend seen so far with SDS-PAGE. Namely, a lower extent of digestion for the infant 705 
model, intermediate values for the early phase adult model and larger extent of digestion for the 706 
late phase adult model. These results support the different extent of hydrolysis of total protein in 707 
both meals across models observed by SDS-PAGE, highlighting the importance of the relevant 708 
human conditions simulated in vitro when digesting whole food matrices.   709 
 710 
 711 
Figure 7: Amount of free amine groups per mass of initial total protein during gastric and intestinal 712 
digestion of bovine milk and soft-boiled hen’s egg with the three models. Different letters mean 713 
significant differences (p ≤ 0.05) between models over time. 714 
 715 
4. Conclusions 716 
Considering that static models of in vitro digestion can only provide physiologically relevant results 717 
at the end points of the gastric and intestinal phases, the conclusions and recommendations in our 718 
study are elaborated in terms of the final extent of proteolysis rather than on kinetics.  719 
An effect of the digestion scenario was seen based on densitometry analysis of intact protein. 720 
Differences were seen in the final extent of gastric and intestinal digestion for isolated proteins and 721 
within the food matrix across the three models of in vitro digestion. In this regard, egg proteins LYS 722 
and OVA either isolated or as part of the egg matrix showed lower, intermediate and larger extent of 723 
gastric and intestinal proteolysis for the infant, early phase and late phase adult model, respectively. 724 
Regarding milk proteins BLG and BCS, only BLG showed lower extent of intestinal proteolysis as part 725 
of the milk matrix in the infant model. More importantly, the total protein digestion in the milk and 726 
egg matrices, quantified by the OPA assay method, followed the trend above for LYS and OVA.  727 
When considering the same in vitro digestion model, the food matrix/processing affected the final 728 
extent of proteolysis (gastric or intestinal). BLG was digested to a lower extent in the intestinal phase 729 
as part of the milk matrix in the infant model. LYS was digested in the gastric phase to a larger extent 730 
with the infant and early phase adult model in the egg matrix, whereas the opposite was observed 731 
for OVA with the two adult models. Therefore, the interaction of proteins with other components in 732 
the food matrix and thermal processing matter even if this is in a liquid/semi-liquid form, which all 733 
have an impact on the final extent of proteolysis. Future investigations on the assessment of protein 734 
digestibility should consider not only the comparison of different human relevant GI conditions, but 735 
also the effect of food matrix and processing relevant to the most likely scenario for the 736 
consumption of the protein under investigation. 737 
The presence of intact protein throughout the intestinal phase, such as BLG, LYS and OVA as part of 738 
the food matrix, may be particularly relevant in infants. Their immature gut is underdeveloped and 739 
allows the absorption of appreciable quantities of intact proteins or large peptide fragments, e.g. 740 
milk proteins, yet not in nutritionally significant amount but enough to be detected in the circulating 741 
blood (4-5 orders of magnitude lower than the oral dose).
44, 45
 In addition, peptides larger than 9 742 
amino acids were present throughout the intestinal phase for all isolated proteins regardless of the 743 
digestion model. This increases the possibility that potential immunoactive peptides encounter the 744 
immune system through the intestinal route. Work correlating persistent peptide sequences from 745 
digesta with binding epitopes positions is still in progress to elucidate differences across in vitro 746 
models for improved risk assessment on allergenicity. Further work will also be needed to assess 747 
whether this is still the case if brush border enzymes and absorption are included as part of the 748 
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